AAMI vs TLX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AAMI · Acadian Asset Management$80.26 ▼ 4.92%
TLX · Telix Pharmaceuticals$8.37 ▼ 3.90%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AAMI +81.9%
- TLX -8.7%
Head to head
| Metric | AAMI | TLX |
|---|---|---|
| Price | $80.26 | $8.37 |
| Change today | ▼ 4.92% | ▼ 3.90% |
| Market cap | $2.83B | $2.84B |
| Return, 3 months | -12.6% | -28.3% |
| Return, year to date | +71.5% | +11.7% |
| Return, 1 year | +86.2% | -6.1% |
| P/E (TTM) | 23.6 | 86.3 |
| P/B | 22.5 | 6.8 |
| P/E percentile vs own 5y | 88th | 40th |
| Dividend yield | 0.39% | – |
| Revenue growth (YoY, latest qtr) | +32.6% | +55.6% |
| Net profit growth (YoY) | +41.1% | -121.2% |
| Gross margin | 42.2% | 53.7% |
| Operating margin | 25.5% | 5.3% |
| Net margin | 17.0% | 3.8% |
| Return on equity | 166.3% | 7.4% |
| Analyst target vs. price | +32.1% | +138.9% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 30 | 34 |
| 30-day volatility | 38.6% | 55.0% |
| Max drawdown, 1 year | -17.7% | -37.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TLX is the largest of the group by market value.
- AAMI has returned the most over the past year.
- AAMI carries the lowest trailing P/E.
- TLX is growing revenue fastest.
- AAMI keeps the most profit per dollar of sales.
- AAMI has been the calmest stock over the last 30 days.